Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen W Freeman

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Current Psychiatry Reports|November 21, 2002
Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorderEllen W Freeman
Women'S Midlife Health|February 16, 2019
Depression in the menopause transition: risks in the changing hormone milieu as observed in the general populationEllen W Freeman
Women'S Health (London, England)|October 7, 2009
Continuing controversies in the recognition and management of premenstrual syndromesEllen W Freeman
Psychoneuroendocrinology|August 2, 2003
Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosisEllen W Freeman
Expert Opinion on Pharmacotherapy|August 7, 2010
Therapeutic management of premenstrual syndromeEllen W Freeman
Women'S Health (London, England)|August 7, 2015
The menopause transition: interview with Ellen W FreemanEllen W Freeman
Maturitas|May 8, 2014
Hot flushes and the menopause: how long should they be expected to last?Ellen W Freeman
CNS Drugs|May 14, 2004
Luteal phase administration of agents for the treatment of premenstrual dysphoric disorderEllen W Freeman
Pharmacoeconomics|May 18, 2005
Effects of antidepressants on quality of life in women with premenstrual dysphoric disorderEllen W Freeman
Social Work|November 1, 1976
Abortion: beyond rhetoric to accessEllen W Freeman
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Current Psychiatry Reports|November 21, 2002
Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorderEllen W Freeman
Women'S Midlife Health|February 16, 2019
Depression in the menopause transition: risks in the changing hormone milieu as observed in the general populationEllen W Freeman
Women'S Health (London, England)|October 7, 2009
Continuing controversies in the recognition and management of premenstrual syndromesEllen W Freeman
Psychoneuroendocrinology|August 2, 2003
Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosisEllen W Freeman
Expert Opinion on Pharmacotherapy|August 7, 2010
Therapeutic management of premenstrual syndromeEllen W Freeman
Women'S Health (London, England)|August 7, 2015
The menopause transition: interview with Ellen W FreemanEllen W Freeman
Maturitas|May 8, 2014
Hot flushes and the menopause: how long should they be expected to last?Ellen W Freeman
CNS Drugs|May 14, 2004
Luteal phase administration of agents for the treatment of premenstrual dysphoric disorderEllen W Freeman
Pharmacoeconomics|May 18, 2005
Effects of antidepressants on quality of life in women with premenstrual dysphoric disorderEllen W Freeman
Social Work|November 1, 1976
Abortion: beyond rhetoric to accessEllen W Freeman
Pageof 12